The Challenges that Motivate Us
Morgridge Institute scientists recognize that a fundamental understanding of human biology will drive the next big advances in human health. We conduct "fearless science" in some of these promising frontiers.
Learn more >
Bringing fluorescence imaging out of the dark
Morgridge Institute spinoff company OnLume had a banner year in 2020, receiving Food and Drug Administration (FDA) approval, meeting its venture funding goals and launching its first clinical trial with a California company. And they are getting expert feedback from UW Health physicians on their groundbreaking fluorescence imaging device.
Building a better bioimaging community: Chan Zuckerberg Initiative supports international partnership
Morgridge Investigator Kevin Eliceiri leads a grant with BioImaging North America, which was recently awarded $1.2 million in funding from the Chan Zuckerberg Initiative.
Where are they now? Morgridge alumni look back (and ahead) at their careers
A few of our Morgridge alumni shared thoughts on their research experience at the Morgridge Institute, their plans moving forward and their warm shoutouts to some of the people who helped them along the way.COVID-19 Research
Many investigators at the Morgridge Institute are taking on new research challenges to help understand the COVID-19 novel coronavirus and defeat the viral outbreak. Research teams in virology, metabolism, regenerative biology and medical engineering have the expertise and technologies uniquely suited to address the pandemic.
Featured EventCOVID-19: The science of vaccines
February 24 @ 4:30 pm
Delve deeper into the science of viruses and vaccines. Experts in virology and vaccine development will share about how coronaviruses infect, how COVID-19 vaccines— including a new class of mRNA vaccines— protect us, and how scientists were able to make the vaccine possible within a year.
Our Mission
Improve human health through innovative, interdisciplinary biomedical discoveries, spark scientific curiosity and serve society through translational outcomes, in partnership with the University of Wisconsin-Madison.